Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02775812
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:36.923388+00:00
Published At
2022-06-10T00:00:00+00:00
Record Updated At
2022-06-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7", "Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-06-10"
protocolSection.identificationModule.nctId
"NCT02775812"
protocolSection.identificationModule.officialTitle
"A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.